Targeting Vascular Inflammation to Reduce Cardiovascular Risk

PROGRAM DESCRIPTION Cardiovascular (CV) disease, specifically coronary heart disease, represents a significant healthcare burden. An improved understanding of the atherothrombotic processes has led to the identification of biomarkers associated with ...

PROGRAM DESCRIPTION
Cardiovascular (CV) disease, specifically coronary heart disease, represents a significant healthcare burden. An improved understanding of the atherothrombotic processes has led to the identification of biomarkers associated with increased CV risk, such as low-density lipoprotein cholesterol and high-sensitivity C-reactive protein, a biomarker for inflammation. In order to address the need to reduce CV events among patients at an increased vascular risk due to elevated levels of C-reactive protein, trials are being conducted to investigate the effect of targeting inflammation to reduce CV risk. Improving knowledge of the role of vascular inflammation (VI) in mediating atherothrombosis will provide the foundation to assess the most recent clinical evidence on the correlation between inflammation and atherothrombosis and the rationale to target inflammatory pathways.

EDUCATIONAL OBJECTIVES
Upon completion of this educational activity, participants should be able to:Discuss the inflammatory processes that contribute to atherothrombosisRecognize the need to target inflammation for the prevention of atherothrombosisEvaluate data from clinical trials targeting VI to reduce recurrence of CV eventsIdentify patients with heart disease that will benefit from anti-inflammatory therapy

---

Write the first review

Resource tags